EUVIMEDEUVIMED entdecken
Crossref

Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential

Farzaneh Mohammadzadeh Rostami, Saman Shalibeik

Archives of Microbiology · 2026

DOI: 10.1007/s00203-026-04731-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Farzaneh Mohammadzadeh Rostami und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology and Virology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Bacteriocins, Antimicrobial Peptides, Antineoplastic Agents, Breast Neoplasms. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer represents a significant therapeutic challenge due to its aggressive behavior and limited treatment options. This study investigates the anticancer potential of microcin H47 (MccH47), a bacteriocin derived from clinical Escherichia coli isolates, against this malignancy. Among 120 screened Enterobacteriaceae isolates, 25 exhibited antimicrobial activity, with isolate 58 confirming MccH47 gene expression through molecular analysis. Cell viability assessment revealed a concentration-dependent reduction in cancer cell survival, while cell death analysis demonstrated approximately 86% apoptosis following 48 h of treatment. Gene expression studies identified significant downregulation of BCL2 and STAT3, indicating involvement of the STAT3/BCL-2 pathway in the observed effects. The extract exhibited biocompatibility toward normal fibroblasts, emphasizing MccH47's dual antimicrobial and antitumor properties with notable therapeutic selectivity. These findings support further development of MccH47 as a novel therapeutic agent for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriocinsAntimicrobial PeptidesAntineoplastic AgentsBreast NeoplasmsTriple Negative Breast NeoplasmsHumansMDA-MB-231 CellsFemaleCell SurvivalApoptosisEscherichia coliSTAT3 Transcription FactorProto-Oncogene Proteins c-bcl-2Cell Line, Tumor

Stichwörter der Autor:innen

Escherichia coliBreast cancerAntimicrobial peptidesCell lineMicrocin H47

Substanzen

BacteriocinsAntimicrobial PeptidesAntineoplastic AgentsmicrocinSTAT3 Transcription FactorProto-Oncogene Proteins c-bcl-2STAT3 protein, humanBCL2 protein, human

Autor:innen und Institutionen

  • Department of Bacteriology and Virology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Microbiology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran. saman.shalibeik@gmail.com.

Zitieren

APA

Mohammadzadeh Rostami, F., & Shalibeik, S. (2026). Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential. Archives of Microbiology. https://doi.org/10.1007/s00203-026-04731-x

Vancouver

Mohammadzadeh Rostami F, Shalibeik S. Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential. Archives of Microbiology. 2026. doi:10.1007/s00203-026-04731-x

BibTeX
@article{MohammadzadehRostami2026,
  author = {Mohammadzadeh Rostami, Farzaneh and Shalibeik, Saman},
  title = {Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential},
  journal = {Archives of Microbiology},
  year = {2026},
  doi = {10.1007/s00203-026-04731-x}
}
Kostenlos starten →